Mavacamten — supply status, manufacturers & alternatives

Mavacamten

—

🇦🇺 AUST R 386127 · Bristol-Myers Squibb Australia Pty Ltd

In supply · Australia

Camzyos

In supply · 🇦🇺 Australia

In supply in Australia

No active shortage reported.

Reading today’s signals…

🇦🇺 AUAEMPA$2160.70DPMQ A$2336.27details →

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Mavacamten

Brand names	Camzyos

Therapeutic category	Auto-created by National Organisation for Medicines — Drug Shortages scraper

Controlled substance	No

Marketing-authorisation holders	Bristol-Myers Squibb Australia Pty Ltd

Registrations on file	4

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 PBS · July 2026

🇦🇺 AU

● Official price on file

Ex-manufacturer

A$2160.70

AEMP

Dispensed (DPMQ)

A$2336.27

incl. fees

Pack

mavacamten 5 mg capsule, 28

Source: PBSEffective July 2026 · AUD

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

12 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Micro Labs LTDMaithri Drugs Private LTDViyash Life Sciences Private LTDMoehs Iberica SlDr Reddys Laboratories LTDDasami Lab Private LTD+6 more

Manufacturing countries: India, Spain, China · Source: FDA List of Drug Master Files

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders4 registrations · 1 MA holder

Product	Strength	Form	Market	MA holder	Status
CAMZYOS mavacamten	10 mg	—	🇦🇺 AU	Bristol-Myers Squibb Australia Pty Ltd	Active
CAMZYOS mavacamten	5 mg	—	🇦🇺 AU	Bristol-Myers Squibb Australia Pty Ltd	Active
CAMZYOS mavacamten	2.5 mg	—	🇦🇺 AU	Bristol-Myers Squibb Australia Pty Ltd	Active
CAMZYOS mavacamten	15 mg	—	🇦🇺 AU	Bristol-Myers Squibb Australia Pty Ltd	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.